Guasp, M, Martin-Aguilar, L, Sabater, L, Bioque, M, Armangue, T, Martinez-Hernandez, E, Landa, J, Maudes, E, Borras, R, Munoz-Lopetegi, A, Saiz, A, Castro-Fornieles, J, Graus, F, Parellada, E, Querol, L, Dalmau, J. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis. NEUROLOGY. 2022; 98(14)DOI:10.1212/WNL.0000000000200021. PMID:35145006. IF:9.900(Q1/1D).

Blanco-Ruiz, M, Martín-Aguilar, L, Caballero-Avila, M, Lleixà, C, Pascual-Goñi, E, Collet-Vidiella, R, Tejada-Illa, C, Turon-Sans, J, Carbayo, A, Llansó, L, Cortés, E, Pascasio, LA, Querol, L. A nationwide Guillain-Barré syndrome epidemiological study in Spain during the COVID-19 years. EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(12)DOI:10.1111/ene.16439. PMID:39132887. IF:3.900(Q1/3D).

Kishnani, PS, Byrne, BJ, Claeys, KG, Díaz-Manera, J, Dimachkie, MM, Kushlaf, H, Mozaffar, T, Roberts, M, Schoser, B, Hummel, N, Kopiec, A, Holdbrook, F, Shohet, S, Toscano, A. Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease. Journal Of Patient-Reported Outcomes. 2024; 8(1)DOI:10.1186/s41687-024-00805-w. PMID:39535661. IF:(Q/D).

Mariscal, A, Martínez, C, Goethals, L, Cortés-Vicente, E, Moltó, E, Juárez, C, Barneda-Zahonero, B, Querol, L, Le Panse, R, Gallardo, E. Modified radioimmunoassay versus ELISA to quantify anti-acetylcholine receptor antibodies in a mouse model of myasthenia gravis. JOURNAL OF IMMUNOLOGICAL METHODS. 2024; 534DOI:10.1016/j.jim.2024.113748. PMID:39241980. IF:1.600(Q4/9D).